Losartan Potassium/Hydrochlorothiazide 50mg/12.5mg Film-Coated Tablets
Out of date information, search another|
1.3.1 |
Losartan potassium + Hydrochlorothiazide |
|
SPC, Labeling and Package Leaflet |
CZ |
PACKAGE LEAFLET: INFORMATION FOR THE USER
<Product name> 50 mg/12.5 mg film-coated tablets Losartan potassium/Hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What <Product name> is and what it is used for
2. Before you take <Product name>
3. How to take <Product name>
4. Possible side effects
5. Storing <Product name>
6. Further information
1. WHAT <PRODUCT NAME> IS AND WHAT IT IS USED FOR
<Product name> is a combination of an angiotensin II receptor antagonist (losartan) and a diuretic (hydrochlorothiazide).
<Product name> is indicated for the treatment of essential hypertension (high blood pressure)
2. BEFORE YOU TAKE <PRODUCT NAME>
Do not take <Product name>
- if you are allergic (hypersensitive) to losartan and/or hydrochlorothiazide or any of the other ingredients of <Product name>;
- if you are more than 3 months pregnant. (It is also better to avoid <Product name> in early pregnancy - see pregnancy section.);
- if you have severely impaired liver function; cholestasis and biliary obstructive disorders
- if you have severely impaired kidney function (i.e. creatinine clearance <30 ml/min);
- if your kidneys are not producing any urine;
- if you have low potassium, low sodium or high calcium levels which cannot be corrected by treatment;
- if you are suffering from gout.
Take special care with <Product name>
- if you have previously suffered from swelling of the face, lips, throat or tongue
- if you take diuretics (water pills)
- if you are on a salt-restricted diet
- if you have or have had severe vomiting and/or diarrhoea
- if you have heart failure
- if you have narrow arteries to your kidneys (renal artery stenosis) or only have one functioning kidney, or you have recently had a kidney transplant
|
1.3.1 |
Losartan potassium + Hydrochlorothiazide |
|
SPC, Labeling and Package Leaflet |
CZ |
- if you have narrowing of the arteries (atherosclerosis), angina pectoris (chest pain due to poor heart function)
- if you have ‘aortic or mitral valve stenosis’ (narrowing of the valves of the heart) or ‘hypertrophic cardiomyopathy’ (a disease causing thickening of heart muscle)
- if you are diabetic
- if you have had gout
- if you have or have had an allergic condition, asthma or a condition that causes joint pain, skin rashes and fever (systemic lupus erythematosus).
- if you have high calcium or low potassium levels or you are on a low potassium diet
- if you need to have an anaesthetic (even at the dentist) or before surgery, or if you are going to
have tests to check your parathyroid function, you must tell the doctor or medical staff that you are taking Losartan potassium and Hydrochlorothiazide tablets.
- if you suffer from primary hyperaldosteronism (a syndrome associated with increased secretion of the hormone aldosterone by the adrenal gland, caused by an abnormality within the gland).
You must tell your doctor if you think that you are (or might become) pregnant. <Product name> is not recommended in early pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Taking other medicines:
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Diuretic agents such as the hydrochlorothiazide contained in <Product name> may interact with other medicines. Preparations containing lithium should not be taken with <Product name> without close supervision by your doctor. Special precautionary measures (e.g. blood tests) may be appropriate if you take potassium supplements, potassium-containing salt substitutes or potassium-sparing medicines, other diuretics (“water tablets”), some laxatives, medicines for the treatment of gout, medicines to control heart rhythm or for diabetes (oral agents or insulins). It is also important for your doctor to know if you are taking other medicines to reduce your blood pressure, steroids, medicines to treat cancer, pain killers, drugs for treatment of fungal infections, or arthritis medicines, resins used for high cholesterol, such as colestyramine, medicines which relax your muscles, sleeping tablets; opioid medicines such as morphine , ‘pressor amines’ such as adrenaline or other drugs from the same group; (oral agents for diabetes or insulins).
Please also inform your doctor when it is planned to apply iodine contrast media about taking <Product name>.
Taking <Product name> with food and drink:
This medicinal product may be taken with or without food.
You are advised not to drink alcohol whilst taking these tablets: alcohol and losartan potassium and hydrochlorothiazide tablets may increase each other’s effects.
Dietary salt in excessive quantities may counteract the effect of losartan potassium and hydrochlorothiazide tablets.
Pregnancy and breast-feeding
Pregnancy
You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking <Product name> before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of <Product name>. <Product name> is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy. Breastfeeding
|
1.3.1 |
Losartan potassium + Hydrochlorothiazide |
|
SPC, Labeling and Package Leaflet |
CZ |
Tell your doctor if you are breast-feeding or about to start breast-feeding. <Product name> is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.
Use in children and adolescents
There is no experience with the use of <Product name> in children. Therefore, <Product name> should not be given to children.
Use in elderly patients
<Product name> works equally well in and is equally well tolerated by most older and younger adult patients. Most older patients require the same dose as younger patients.
Driving and using machines:
When you begin treatment with this medication, you should not perform tasks which may require special attention (for example, driving an automobile or operating dangerous machinery) until you know how you tolerate your medicine.
Important information about some of the ingredients of <Product name>:
This product contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
3. HOW TO TAKE <PRODUCT NAME>
Always take <Product name> exactly as your doctor has told you. Your doctor will decide on the appropriate dose of <Product name> depending on your condition and whether you are taking other medicines. It is important to continue taking <Product name> for as long as your doctor prescribes it in order to maintain smooth control of your blood pressure.
High Blood Pressure
The usual dose of <Product name> for most patients with high blood pressure is 1 tablet of <Product name> 50 mg/12.5 mg per day to control blood pressure over the 24-hour period. This can be increased to 2 tablets once daily of <Product name> 50 mg/12.5 mg film-coated tablets or changed to 1 tablet daily of <Product name> 100 mg/25 mg film-coated tablets (a stronger strength) per day. The maximum daily dose is 2 tablets per day of <Product name> 50 mg/12.5 mg film-coated tablets or 1 tablet daily of <Product name> 100 mg/25 mg film-coated tablets.
If you take more <Product name> than you should:
In case of an overdose, contact your doctor immediately so that medical attention may be given promptly. Overdosage can cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration.
If you forget to take <Product name>
Try to take <Product name> daily as prescribed. However, if you miss a dose, do not take an extra dose. Just resume your usual schedule.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, <Product name> can cause side effects, although not everybody gets them.
|
1.3.1 |
Losartan potassium + Hydrochlorothiazide |
|
SPC, Labeling and Package Leaflet |
CZ |
The frequency of side effects is classified in following categories
|
Very common: |
affects more than 1 user in 10 |
|
Common: |
affects 1 to 10 users in 100 |
|
Uncommon: |
affects 1 to 10 users in 1,000 |
|
Rare: |
affects 1 to 10 users in 10,000 |
|
Very rare: |
affects less than 1 user in 10,000 |
|
Not known: |
frequency cannot be estimated from available data |
If you experience the following, stop taking <Product name> tablets and tell your doctor immediately or go to the casualty department of your nearest hospital:
A severe allergic reaction (rash, itching, swelling of the face, lips, mouth or throat that may cause difficulty in swallowing or breathing).
This is a serious but rare side effect, which affects more than 1 out of 10,000 patients but fewer than 1 out of 1,000 patients. You may need urgent medical attention or hospitalisation.
The following side effects have been reported:
Common (affecting less than one person in 10 but more than one person in 100):
- Cough, upper airway infection, congestion in the nose, sinusitis, sinus disorder,
- Diarrhoea, abdominal pain, nausea, indigestion, □
- Muscle pain or cramps, leg pain, back pain,
- Insomnia, headache, dizziness,
- Weakness, tiredness, chest pain,
- Increased potassium levels (which can cause an abnormal heart rhythm), decreased haemoglobin
levels.
Uncommon (affecting less than one person in 100 but more than one person in 1,000):
- Anaemia, red or brownish spots on the skin (sometimes especially on the feet, legs, arms and buttocks, with joint pain, swelling of the hands and feet and stomach pain), bruising, reduction in white blood cells, clotting problems and bruising,
- Loss of appetite, increased uric acid levels or frank gout, increased blood sugar levels, abnormal blood electrolyte levels,
- Anxiety, nervousness, panic disorder (recurring panic attacks), confusion, depression, abnormal dreams, sleep disorders, sleepiness, memory impairment,
- Pins and needles or similar sensations, pain in the extremities, trembling, migraine, fainting,
- Blurred vision, burning or stinging in the eyes, conjunctivitis, worsening eyesight, seeing things in yellow,
- Ringing, buzzing, roaring or clicking in the ears,
- Low blood pressure, which may be associated with changes in posture (feeling light-headed or weak when you stand up, angina (chest pain), abnormal heartbeat, cerebrovascular accident (TIA, “mini-stroke”), heart attack, palpitations,
- Inflammation of blood vessels, which is often associated with a skin rash or bruising,
- Sore throat, breathlessness, bronchitis, pneumonia, water on the lungs (which causes difficulty breathing), nosebleed, runny nose, congestion, □
- Constipation, wind, stomach upsets, stomach spasms, vomiting, dry mouth, inflammation of a salivary gland, toothache,
- Jaundice (yellowing of the eyes and skin), inflammation of the pancreas,
- Hives, itching, inflammation of the skin, rash, redness of the skin, sensitivity to light, dry skin, flushing, sweating, hair loss,
- Pain in the arms, shoulders, hips, knees or other joints, joint swelling, stiffness, muscle weakness,
|
1.3.1 |
Losartan potassium + Hydrochlorothiazide |
|
SPC, Labeling and Package Leaflet |
CZ |
- Frequent urination including at night, abnormal kidney function including inflammation of the kidneys, urinary infection, sugar in the urine,
- Decreased sexual appetite, impotence,
- Swelling of the face, fever.
Rare (more than 1 out of10000 patients and less than 1 out of1000 patients)
- Hepatitis (inflammation of the liver), abnormal liver function tests
Not known (frequency cannot be estimated from available data)
- Rhabdomyolisis
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
5. HOW TO STORE <PRODUCT NAME>
Keep out of the reach and sight of children.
Do not use <Product name> after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
Do not store above 30°C. Store in the original blister in order to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What <Product name> contains
- The active substances are losartan potassium and hydrochlorothiazide. Each film-coated tablet contains 50 mg losartan potassium, equivalent to 45.76 mg losartan and 12.5 mg hydrochlorothiazide.
- The other ingredients are:
in the core - pregelatinised maize starch; microcrystalline cellulose; lactose monohydrate; magnesium stearate;
in the coating - hypromellose; macrogol 4000; quinoline yellow (E104); talc; titanium dioxide (E171).
What <Product name> looks like and contents of the pack
<Product name> tablets are yellow, oval, moderately biconvex, film-coated tablets with one-sided halving score, tablet dimension 6 mm x 12 mm (oval shape) thickness 3.8 - 4.7 mm. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
Tablets are supplied in cartons containing 10, 14, 28, 30, 56, 60, 84, 90 and 98 film-coated tablets in Al/PVC/PVDC transparent blisters.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
<To be completed nationally>
|
1.3.1 |
Losartan potassium + Hydrochlorothiazide |
|
SPC, Labeling and Package Leaflet |
CZ |
Manufacturer
1. KRKA, d.d., Novo mesto, Smarjeska cesta 6, 8501 Novo mesto, Slovenia
2. TAD Pharma GmbH, Heinz-Lohmann-StraBe 5, 27472 Cuxhaven, Germany
This medicinal product is authorised in the Member States of the EEA under the following names:
|
Name of the Member State |
Name of the medicinal product |
|
AT |
Losartan/HCT Krka |
|
CZ |
Lorista H |
|
CY |
Losartan/Hydrochlorothiazide Krka |
|
DE |
Losartan-Kalium HCTad |
|
DK |
Losartankalium/hydrochlorthiazid Krka |
|
EE |
Lorista H |
|
FI |
Losartan/Hydrochlorothiazide Krka |
|
HU |
Lavestra H |
|
IE |
Lozitar Comp |
|
IT |
Losartan e Idroclorotiazide Krka |
|
LV |
Lorista H |
|
NO |
Losartan/Hydrochlorothiazide Krka |
|
PL |
Lorista H |
|
PT |
Losartan/Hidroclorotiazida Krka |
|
SE |
Losartan/Hydrochlorothiazide Krka |
|
SK |
Lorista H |
|
UK |
Losartan Potassium/Hydrochlorothiazide |
This leaflet was last approved in {MM/YYYY}
SmPCPIL046464 1 17.01.2014-Updated: 17.01.2014 Page 29 of 29